Breast Cancer Screening

The Future of Breast Imaging – Hologic Clarity HD High-Resolution 3D® Technology

July 19, 2022
The Future of Breast Imaging – Hologic Clarity HD High-Resolution 3D® Technology

As the technology in phones, computers, and cars evolve, so does the technology used in your mammogram. The clearer the images, the more confident your radiologist can be in their diagnosis. That’s why Hologic created the Genius® exam with Hologic Clarity HD High-Resolution 3D® Technology, the industry’s highest-resolution imaging technology.

What Makes a Mammogram High-Resolution?

Everyone enjoys a sharper picture, whether it’s your TV show, social media photos, or video streaming. Technology enhances these visuals so they’re as clear as possible, and it’s no different for breast imaging. Hologic Clarity HD High-Resolution 3D® Technology enhances images so radiologists can better view the details of your mammogram. This means suspicious lumps or calcifications appear clearer, and radiologists feel more confident in what they’re reviewing.

Dr. Georgia Giakoumis Spear, Chief of the Department of Breast Imaging at NorthShore University Health System, said, “Our radiologists have unanimously expressed greater confidence when we’re reading cases with Hologic Clarity HD High-Resolution 3D® Technology. We feel much more confident in the resolution and the image quality that we are seeing.”1

The Genius® 3D exam with Hologic Clarity HD High-Resolution 3D® Technology improves the sharpness and smoothness of images so radiologists can better view lesions for increased clinical confidence and improved radiologist detection compared to Hologic standard 3D™ imaging.2-5 This is important because early detection often means a better outcome. In fact, the five-year survival rate is 99% for breast cancers found before they have spread.6

Clarity HD Technology Quick Facts

  • Crystal-Clear Images: The Genius® 3D Mammography exam with Hologic Clarity HD High-Resolution 3D® Technology produces clearer and more detailed images of the breast with two times the resolution of a standard resolution 3D Mammography exam. Your radiologist can view images that look sharper and more natural, helping them better define calcifications or potential tumors.
  • Increased Confidence: With sharper pictures and high-resolution 3D imaging, your doctors can more confidently identify a suspicious area and determine next steps, such as a follow-up exam or biopsy, if needed. Increased diagnostic confidence ensures that your breast cancer journey is as smooth as possible.2-5
  • Peace of Mind: The Genius® 3D exam with Hologic Clarity HD High-Resolution 3D® Technology can cut follow-up appointments by up to 40% compared with 2D imaging alone.7-10 Spend less time worrying about potential follow-up exams and more time focusing on you!

Getting a mammogram shouldn’t be scary, and you shouldn’t worry that your exam could miss something. The Genius® 3D exam with Hologic Clarity HD High-Resolution 3D® Technology quickly captures crystal-clear images and boosts the confidence of both you and your doctor.*

Ask your healthcare practitioner if they offer Hologic Clarity HD High-Resolution 3D® Technology or use our facility finder to check if there’s a site in your area.

* Feature is used in combination with SecurView® DX diagnostic review workstation mapping tool in v9.0.1 and above.
The Genius® 3D Mammography™ exam is acquired on the Hologic® 3D Mammography™ system and consists of a 2D and 3D™ image set, where the 2D image can be either an acquired 2D image or a 2D image generated from the 3D™ image set. The Genius® exam is only available on the Hologic® 3D Mammography™ system.
[TRADEMARK ATTRIBUTION] Hologic, Inc. 3D, 3D Mammography, Hologic Clarity HD, Dimensions, Genius, Hologic, Selenia, The Science of Sure, and associated logos are trademarks and/or registered trademarks of Hologic, Inc. and/or its subsidiaries in the U.S. and/or other countries.
[DISCLAIMER] The content in this piece is for information purposes only and is not intended to be medical advice. Please contact your medical professional for specific advice regarding your health and treatment. This information may be relevant in the U.S. and other markets and is not intended as a product solicitation or promotion where such activities are prohibited. Because Hologic materials are distributed through websites, eBroadcasts and tradeshows, it is not always possible to control where such materials appear. Views and opinions expressed herein by third parties are theirs alone and do not necessarily reflect those of Hologic. Dr. Georgia Giakoumious Spear is a paid Hologic consultant. For specific information on what products may be available in a particular country, please write to womenshealth@hologic.com.
  • 1 Georgia Giakoumis Spear, M.D. User Experience with Hologic Clarity HD™ and Intelligent 2D™ Technology WP-00143 Rev 002 (10/19) US/International © 2019 Hologic, Inc.

    2 Tech File: TFL-00059

    3 Report: CSR-00116

    4 Physician Labeling: MAN-06153

    5 FDA Submission: P080003/S008

    6 Survival rates for breast cancer. American Cancer Society. (n.d.). Retrieved March 23, 2022, from https://www.cancer.org/cancer/breast-cancer/understanding-a-breast-cancer-diagnosis/breast-cancer-survival-rates.html

    7 Friedewald SM, Rafferty EA, Rose SL, et al. Breast cancer screening using tomosynthesis in combination with digital mammography. JAMA. 2014 Jun 25;311(24):2499-507.

    8 Zuckerman SP, Conant EF, Keller BM, et al. Implementation of Synthesized Two-dimensional Mammography in a Population-based Digital Breast Tomosynthesis Screening Program. Radiology. 2016 Dec;281(3):730-736.

    9 Skaane P, Bandos A, Eben EB, et al. Two-view digital breast tomosynthesis screening with synthetically reconstructed projection images: comparison with digital breast tomosynthesis with full-field digital mammographic images. Radiology. 2014 Jun;271(3):655-63

    10 Bernardi D, Macaskill P, Pellegrini M, et. al. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study. Lancet Oncol. 2016 Aug;17(8):1105-13.